"Designing Growth Strategies is in our DNA"

Respiratory Drugs Market Size, Share & Industry Analysis, By Drug Class (Short-Acting Beta2-Agonists, Long-Acting Beta2-Agonists, Inhaled Corticosteroids, Anticholinergics, Antihistamines) By Disease Type (Asthma, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Pleural Effusion), By Route of Administration (Inhalation, Enteral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Fore

Region : Global | Report ID: FBI101421 | Status : Ongoing

 

KEY MARKET INSIGHTS

Respiratory drugs are the medications used for the treatment of various respiratory diseases. With the growing population, adoption of sedentary lifestyle, and rising incidences of pulmonary disease globally will increase the demand for the effective respiratory drugs. According to World Health Organization (WHO) it was estimated that 251 million cases of chronic obstructive pulmonary disease (COPD) were registered.


Frequent respiratory infections, and increased exposure to indoor & outdoor air pollution and chemicals occupational dust, and growing smoking population globally are likely to boost the demand for innovative drugs for treatment of respiratory diseases. Presence of strong pipeline drugs is anticipated to fuel the respiratory drugs market growth during the forecast period


To gain extensive insights into the market, Request for Customization


Growing adoption of innovative drugs for the treatment of various respiratory diseases and increase in the investments in R&D activities by major key players are likely to drive the respiratory drugs market growth during the forecast period. Additionally, growing patient population and growing demand for drugs for the treatment of respiratory diseases are expected to augment the respiratory drugs market growth during the forecast period.


However, stringent regulatory scenario for the approval of many drugs for the treatment of respiratory diseases is likely to hinder the respiratory drugs market growth during the forecast period.


Key Players Covered


Some of the major companies that are present in the global respiratory drugs market report include VAPOTHERM, AptarGroup, Inc., Drägerwerk AG & CO., Allied Healthcare, Cardinal Health, NSPIRE HEALTH INC. oninklijke Philips N.V., and others


Segmentation






























 ATTRIBUTE


 DETAILS

By Drug Class




  • Short-Acting Beta2-Agonists (SABA)

  • Long-Acting Beta2-Agonists (LABA)

  • Inhaled Corticosteroids (ICS)

  • Anticholinergics

  • Antihistamines

  • Vasodilators

  • Combination Drugs

  • Others



By Disease Type




  • Asthma

  • Chronic Bronchitis

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Pleural Effusion

  • Others



By Route of Administration




  • Inhalation

  • Enteral

  • Parenteral



By Distribution Channel




  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies



By Geography




  • North America (the USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



In terms of drug class, combination drugs segment is anticipated to hold the respiratory drugs market share during the forecast period as they are more effective that other drugs and are easily affordable due to their low cost.


Key Insights



  • Overview of pipeline drugs for respiratory disease treatment

  • The Regulatory scenario for key countries

  • Key Industry Developments –mergers, partnerships, and acquisitions


 Regional Analysis


The global respiratory drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Asia and Africa. North America is anticipated to hold the largest respiratory drugs market share during the forecast period owing to the presence of prominent key market players in U.S. and growing strategic partnerships among these key players in launching of new products. In Europe rising awareness about innovative respiratory drugs are anticipated to drive the respiratory drugs market growth during the forecast period. Growing patient population and penetration of generic drugs for the treatment of various respiratory drugs are likely to boost the respiratory drugs market growth in Asia Pacific region. In Middle East & Africa the growing unmet need for the effective drugs for the treatment of respiratory diseases is anticipated to drive the respiratory devices market growth during the forecast period.


Key Industry Developments



  • In March 2019, Circassia. Received FDA approval for the use of Tudoorza for the maintenance& treatment of chronic obstructive pulmonary disease (COPD)

  • In November 2018, Theravance Biopharma and Mylan N.V. received approval from FDA for New Drug Application (NDA) for YUPELRITM (revefenacin) inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).


Respiratory Drugs Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Roche
Amgen
Pfizer
Johnson
Ipsos

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X